6 but, if the male to female sex ratio in rectal cancer starts about 1: 1 and then changes to 2: 1 with increasing age, then clearly the lines for male and female rates cannot be parallel. If there are two straight lines then a constant divergence as in Fig lB could explain the changing sex ratio but, if the lines are not straight then, for instance, the male rate of increase might become greater with age or the female become less pronounced, the situations shown by the continuous lines in Fig 1A. The importance of these theoretical possibilities is that we have little knowledge of carcinogenic influences in the large intestine and therefore any information which localized the search, for instance to men of over a certain age, would be useful. Unfortunately a simple graphical plot on logarithmic scales does not give any definite information about the sources of the observed changes of sex ratio in cancer of the rectum, for variations between samples obscures the real trend. By incorporating data from many different areas and carrying out more sophisticated analyses the difficulties may be solved but the mathematical problems are considerable. REFERENCES Clemmesen J (1964) Statistical Studies in the kEtiology of Malignant Neoplasms.
but, if the male to female sex ratio in rectal cancer starts about 1: 1 and then changes to 2: 1 with increasing age, then clearly the lines for male and female rates cannot be parallel. If there are two straight lines then a constant divergence as in Fig lB could explain the changing sex ratio but, if the lines are not straight then, for instance, the male rate of increase might become greater with age or the female become less pronounced, the situations shown by the continuous lines in Fig 1A. The importance of these theoretical possibilities is that we have little knowledge of carcinogenic influences in the large intestine and therefore any information which localized the search, for instance to men of over a certain age, would be useful. Unfortunately a simple graphical plot on logarithmic scales does not give any definite information about the sources of the observed changes of sex ratio in cancer of the rectum, for variations between samples obscures the real trend. By incorporating data from many different areas and carrying out more sophisticated analyses the difficulties may be solved but the mathematical problems are considerable.
In spite of the advances of modern surgical and anmsthetic techniques, between 40 and 50 of every hundred patients with carcinoma of the colon and rectum are dead within five years from metastases or recurrent disease. In part this must be due to delays in diagnosis and treatment but it must also be caused partly by the dissemination of tumour cells at the time of operation. The local application of antitumour agents at the cut ends of the colon in resection is well established in the prevention of anastomotic recurrences. "Present address: Metropolitan Hospital, London, E8 Whilst the precise significance of the circulating malignant cell in relation to prognosis has yet to be determined, there is no doubt that tumour cells can be demonstrated in the blood stream and, most frequently, at the time of operation . Salsbury (1966) has isolated malignant cells from the circulation in 25 out of 50 patients undergoing excision of carcinomas of the rectum or colon; multiple samples were taken from an antecubital vein, this high incidence being observed only during operation at the time of activity in the region of the tumour. In a further series of 50 patients , two blood samples only were taken from the common iliac vein prior to removal of sigmoid or rectal growths. Malignant cells were found circulating in 60% of these cases and in 42% (the largest group) only after ligation of the inferior mesenteric vein, when the main venous drainage of the tumour is diverted to the systemic circulation.
There is therefore little doubt that chemotherapy could be useful as an adjuvant to radical surgery in the early stages of the disease. This role would be quite different from the use of antitumour drugs in the palliation of extensive or inoperable disease, a field in which there have already been many disappointing reports of local or systemic treatment.
The ultimate value of this type of treatment will be determined clinically and by follow-up studies but, because chemotherapeutic agents have a poor reputation in cases of intestinal malignancy, and because the drugs themselves may exert a considerable toxic effect on the patient and on the balance between tumour and host, it seemed important to attempt a study of the behaviour of such a drug in an experimental system before applying it to the patient.
To this end we developed a technique of in vitro perfusion of the arterial system of the operative specimen as soon as it was removed from the patient. A Dale-Schuster perfusion pump (Dale & Schuster 1928) was used with an oxygenated physiological saline-dextran solution. In a preliminary series of 36 perfusions it was possible to demonstrate the release of malignant cells into the venous perfusate in three-quarters of the cases under certain circumstances. Among the factors involved in this release was the presence of a fibrinolytic agent in the arterial perfusion fluid and, to a lesser extent, manipulation of the tumour and vigorous contraction of the bowel.
Certain features of the anatomy of the blood supply of these tumours have been demonstrated by the injection of dyes and of radiopaque gelatin, findings which have been reported to the Surgical Research Society by Smart et al. (1963) and by Griffiths (1965) .
In summary, this work has shown that certain areas of carcinomas of the rectum and colon are not reached by dyes given by the arterial routean observation made in vivo and in the isolated perfused preparation. X-rays of the vascular tree of such growths show a hyperemic zone at the tumour edge and a tendency to avascularity in the centre. The variations between growths of different types lie between the ulcerating cancer with an avascular centre and the proliferative type of tumour with a marked vascular pattern in which, however, areas of poor blood supply can still be seen. Much of the hyperaemic zone at the growing edge of the tumour is probably due to submucosal venous stasis and (proximal) dilatation of the vessels in the mucosal plexus.
At the Royal Marsden Hospital a pump perfusion apparatus has been developed incorporating a disposable Rygg-Kyvsgaard oxygenator.
Together with the addition of human red cells to a perfusion fluid of improved electrolyte composition, this has allowed the perfusion of colon and rectal tumours for two to three hours under conditions which are as nearly physiological as possible and without hazard to the patient.
In 6 such perfusions tritiated thymidine has been injected intra-arterially within one hour of starting the experiment. Thymidine is taken up by cells which are in course of synthesis of deoxyribonucleic acid (DNA) and when the thymidine is labelled with radioactive tritium (3H) these cells may be demonstrated autoradiographically by exposure of histological slices to suitable photographic emulsion. In these perfused specimens the uptake of 3H-thymidine has been seen in the crypt cells of normal mucosa, in cells of the germinal centres of the lymph nodes and in tumour cells. These observations confirm that this is a viable type of preparation in which to study drug distribution since, in the final analysis, the naked-eye appearances of a dye within a tumour can only suggest the regions accessible to an antitumour agent.
There are a number of problems in obtaininig labelled anti-cancer drugs: these include the difficulties and expense involved in preparing a complex organic compound and the uncertainty that the label has been incorporated into the active part of the molecule. In this study we have been fortunate to use an alkylating agent which has been extensively studied already both biologically and chemically at the Chester Beatty Research Institute. 35S-labelled mustard gas, di(2-chloroethyl) 3aS sulphide, is a highly toxic, highly volatile, ether-soluble alkylating agent of the difunctional type; it is rapidly hydrolysed in contact with water or blood and has a short biological half-life because of this. These facts make administration difficult but it has been diluted in ten to twenty times its own volume of saline and rapidly injected into the arterial side of the perfusion as close to the preparation as possible. An arteriogram of such a specimen shows thin vessels and poor filling which may be due to spasm induced by the mustard. Autoradiographs of such tissues are not as clear cut in interpretation as those labelled with tritiated thymidine but they do demonstrate widespread infiltration of normal and tumour tissue.
A quantitative study of the distribution of the sulphur-labelled mustard gas has been carried out in radiochemical assays by Dr P D Lawley, at the Chester Beatty Research Institute. In one such experiment (Table 1 ) he has determined the blood level of the mustard and its concentration in the protein of the cellular constituents of various parts of the specimen. This was done by estimating the radioactivity in that fraction which was insoluble in cold 5 %trichloroaceticacid(TCA). In the normal mucosa and in the edge of the tumour there is a concentration of mustard between five and six times that in the blood but this is not found in the avascular centre of the tumour.
In studies of other mammalian tumour systems both in vivo and in vitro, Brookes & Lawley (1961 , 1965 have shown that the chemical reactions of sulphur mustard with tissues include alkylation of nucleic acids and of ring-nitrogen atoms within them, with the production of certain endproductsprincipally 7-alkyl guanines. It seems reasonable to assume that the chemical reactions occurring in these human tumours are of a similar nature to those observed in animal tumours. The extent of reaction has also been represented in Table 1 , therefore, as the number of alkylations per DNA molecule (in which an approximate assumption of the molecular weight is made at 6-7 x 106 -the exact figure being unknown). On a similar basis the mean lethal dose of sulphur mustard to mammalian tumour cells in tissue culture is 0-02 alkylations per DNA molecule (Crathorn & Roberts 1966) .
In summary, these figures indicate that the administration of a difunctional alkylating agent at a dosage of 0-14 mg/kg (cf. nitrogen mustard in clinical use) will produce an effective alkylation of DNA and, therefore, interfere with its functions in cell division in those parts of the tumour which are adequately perfused, particularly at the margin of the tumour wherein are likely to be the sites of origin of hematogenous spread. Since these results have been confirmed in similar experiments-in which even higher tissue concentrations of mustard have been obtainedthe repetition of similar tracer experiments in the patient seemed justified.
Here we have used 35S-labelled 'half-sulphur mustard', 2-hydroxyethyl-2-chloroethyl 35S sulphide, because this is much less toxic than the mustard gas and it is slightly easier to administer. Its chemical alkylation of DNA resembles the more powerful agent although this one is only of the monofunctional type. The radioactive dose of approximately 1 mc given to the patient is very small and a cannula in the inferior mesenteric vein allows for diversion from the general circulation. This dose was injected through a cannula in the inferior mesenteric artery prior to a resection of a carcinoma of the sigmoid colon. The drug solution also contained patent blue violet to indicate its macroscopic distributionagain patchy areas of poor staining were seen on the luminal and cut surfaces of the tumour.
The assay of this specimen is shown in Table 2 . The local venous blood level indicates a dosage nearly twenty times as great as the in vitro dosage of the mustard gas and the leak into the systemic circulation dilutes it a hundred times. In addition to assays of the TCA insoluble fraction (protein and nucleic acids), Dr Lawley has determined the reaction in protein extracted by another method (methanol precipitation of phenol-soluble material) and in extracted tumour DNA. These figures show similar levels of mustard concentration in micrograms mustard per gram protein to those seen in vitro but, of course, these are much lower relative to the local blood level. It will be noted that the highest concentration of the drug was obtained in the protein of a local lymph node, a fact which may be of considerable therapeutic value.
The low levels of reaction in the relatively avascular parts of such tumours may offer some explanation of the poor long-term results achieved by radiomimetic agents when used in extensive disease (when many parts of the tumour may have a poor blood supply). 
Conclusions
(1) The intra-arterial administration of a labelled alkylating agent -35S mustard gasto isolated perfused tumours of the rectum and colon enables the drug to reach the growing edge and vascular parts of the tumours in a concentration lethal to malignant cells.
(2) This has been confirmed in a patient using the less toxic agent -35S 'half-sulphur mustard' -and in addition the drug reaches local lymph nodes in a lethal concentration.
(3) These findings provide a rational basis for the adjuvant use of alkylating agents at the time of operation in an attempt to inactivate those cells which are released into the circulation at subsequent manipulation and in order also to 'sterilize' any malignant cells which have spread to lymph nodes that may not be included in the field of excision.
(4) The toxic effects to the patient and the possible interference with the host-tumour resistance should be minimized by: (a) The use of a drug with a short biological half-life. (b) Local arterial injection early in the operation. (c) The use of a heparinized venous cannula to divert excess dosage from the general circulation.
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